IDENTIFICATION AND VALIDATION OF NOVEL COMBINATION THERAPIES FOR KRAS-MUTATED COLORECTAL CANCER USING UNBIASED AND INNOVATIVE SCREENING STRATEGIES
$625,345FY2019Defense Health AgencyDOD
The Univeristy Of Texas M.D. Anderson Cancer Center
The Univeristy Of Texas M.D. Anderson Cancer Center